Hypothyroidism determines the clinical and immunological manifestations of Arabs with lupus

Abstract

Data on thyroid disease in Arabs with lupus is scarce. We conducted a cross-sectional and retrospective case–control study to report the prevalence of thyroid diseases in 110 Arabs with lupus who attended our Rheumatology Clinic between January 2002 and January 2007, and to delineate the clinical and immunological features of Arabs lupus patients with thyroid diseases. We found hypothyroidism in 15 (13.7%) patients. Overall, 25.6% had elevated thyroid peroxidase antibodies, 14.6% had elevated anti-thyroglobulin antibodies, and 13.7% were positive for both antibodies. Lupus patients with hypothyroidism had a significantly higher frequency of polyarthritis (OR = 9.3, CI: 2.0–41.7, P < 0.001), cutaneous manifestations (OR = 5.6, CI: 2.4–14.3, P < 0.0001), positive anti-thyroglobulin antibodies (OR = 19.9, CI: 8.38–47.4, P < 0.0001), and thyroid peroxidase antibodies (OR = 12.3, CI: 6.27–24.1, P < 0.0001) than lupus patients with normal thyroid function. Furthermore, neuropsychiatric (OR = 0.36, CI: 0.14–0.93, P < 0.05) and hematological (OR = 0.52, CI: 0.29–0.91, P < 0.05) manifestations were significantly lower in patients with hypothyroidism than in euthyroid patients. Surprisingly, the prevalence of anticardiolipin antibody immunoglobulin G (aCL IgG) (OR = 0.34, CI: 0.13–0.86, P < 0.05), lupus anticoagulant (OR = 0.02, CI: 0.001–0.35, P < 0.0001), and anticardiolipin syndrome (OR = 0.02, CI: 0.001–0.43, P < 0.0001) were significantly lower in lupus patients with hypothyroidism than in lupus patients with normal thyroid function. In conclusion, the prevalence of hypothyroidism in Arabs with lupus is comparable to that reported in the literature. Arab lupus patients with hypothyroidism have distinctive clinical and immunological features that differentiate them from euthyroid patients.

Keywords

anticardiolipin antibodies Arabs systemic lupus erythematosus thyroid

Get full access to this article

View all access options for this article.

References

1 Jara LJ Navarro C Brito-Zerón MP . Thyroid disease in Sjögren’s syndrome. Clin Rheumatol 2007; 10: 1601 – 1666 .

2 Antonelli A Ferri C Fallahi P . Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 2007; 4: 431 – 437 .

3 Sakata S Fuwa Y Goshima E . A case of Graves’ disease associated with polymyositis. J Endocrinol Invest 1989; 11: 837 – 840 .

4 Miller FW Moore GF Weintraub BD Steinberg AD . Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum 1987; 10: 1124 – 1131 .

5 Goh KL Wang F . Thyroid disorders in systemic lupus erythematosus. Ann Rheum Dis 1986; 45: 579 – 583 .

6 Weetman AP Walport MJ . The association of autoimmune thyroiditis with systemic lupus erythematosus. Br J Rheumatol 1987; 5: 359 – 361 .

7 Baker JR Miller FW Steinberg AD Burman KD . Thyroid stimulating and thyrotropin binding-inhibitory immunoglobulin activity in patients with systemic lupus erythematosus having thyroid function abnormalities. Thyroid 1991; 3: 229 – 234 .

8 Vianna JL Haga HJ Asherson RA Swana G Hughes GR . A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus. J Rheumatol 1991; 8: 1193 – 1195 .

9 Athanassiou P; Kostoglou-Athanassiou I; Galanaki C; . Antithyroid antibodies and autoimmune thyroid disease in patients with systemic lupus erythematosus. Ann Rheum Dis 2006; 65(Suppl. 2): 193 (abstract THU0251).

10.

10 Hollowell JG Staehling NW Flanders WD . Serum TSH, T(4), and thyroid antibodies in the United States population (1988 o1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 2: 489 – 499 .

11.

11 Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725 .

12.

12 Al-Saleh J Jassim V El-Sayed M Saleh N Harb D . Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus 2008; 17: 62 – 66 .

13.

13 Fitzgerald JD Grossman JM . Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients. Lupus 1999; 8: 638 – 644 .

14.

14 Pyne D Isenberg DA . Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 2002; 1: 70 – 72 .

15.

15 Mader R Mishail S Adawi M Lavi I Luboshitzky R . Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity. Clin Rheumatol 2007; 11: 1891 – 1894 .

16.

16 Konstadoulakis MM Kroubouzos G Tosca A . Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function. Thyroidology 1993; 1: 1 – 7 .

17.

17 Park DJ Cho CS Lee SH Park SH Kim HY . Thyroid disorders in Korean patients with systemic lupus erythematosus. Scand J Rheumatol 1995; 1: 13 – 17 .

18.

18 Boey ML Fong PH Lee JS Ng WY Thai AC . Autoimmune thyroid disease in SLE in Singapore. Lupus 1993; 2: 51 – 54 .

19.

19 Tsai RT Chang TC Wang CR Chuang CY Chen CY . Thyroid disorders in Chinese patients with systemic lupus erythematosus. Rheumatol Int 1993; 13: 9 – 13 .

20.

20 Lazarus JH Obuobie K . Thyroid disorders—an update. Postgrad Med J 2000; 899: 529 – 536 (review).

21.

21 Yamamoto M Saito S Sakurada T . Effect of prednisolone and salicylate on serum thyroglobulin level in patients with subacute thyroiditis. Clin Endocrinol (Oxf) 1987; 3: 339 – 344 .

22.

22 Kaufman KM Kelly JA Herring BJ . Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum 2006; 8: 2533 – 2540 .

23.

23 Wu H Cantor RM Graham DS . Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 2005; 8: 2396 – 2402 .

24.

24 Ligier S Pham CD Watters AK Kassis J Fortin PR . Purpura fulminans and anticardiolipin antibodies in a patient with Grave’s disease. Scand J Rheumatol 2002; 6: 371 – 373 .

25.

25 Takahashi A Tamura A Ishikawa O . Antiphospholipid antibody syndrome complicated by Grave’s disease. J Dermatol 2002; 12: 776 – 780 .

26.

26 Innocencio RM Romaldini JH Ward LS . Thyroid autoantibodies in autoimmune diseases. Medicina (B Aires) 2004; 3: 227 – 230 .

27.

27 De Carolis C Greco E Guarino MD . Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters. Am J Reprod Immunol 2004; 4: 263 – 266 .

28.

28 Uthman I Salti I Khamashta M . Endocrinologic manifestations of the antiphospholipid syndrome. Lupus 2006; 8: 485 – 489 (review).